Please login to the form below

Not currently logged in
Email:
Password:

Calchan names Zahid Ali as chief scientific officer

Ali joins from Pfizer where he was a senior director

edit-calchan-zahid-aliUK-based biotech company Clachan has appointed Zahid Ali as chief scientific officer.

Calchan works with a focus on research and development of novel molecules targeting pain and imflammation, complementing Ali's two decades of industry experience and extensive knowledge of the area.

Commenting on his appointment, Ali said: “I am very excited to be joining Calchan, which has a management team of enviable experience and a very successful track record in the sector. 

“I believe the company's products have significant potential and I am looking forward to working with the team to secure Calchan's position as a leader in this field.”

Ali joins from Pfizer, where he held the position of senior director of clinical research and was responsible for a number of early clinical development programmes focused on pain research.

He began his career at Merck Sharp and Dohme Research Laboratories UK before increasing his seniority at companies including GSK, where he worked as director of discovery medicine.

Brenda Reynolds, CEO at Calchan, added: “Zahid Ali's appointment is an important one as we continue to assemble a strong team to develop our assets at Calchan. I am delighted that Zahid has chosen to join us as his considerable experience and background, notably as a Clinical Director at Pfizer, will be invaluable.”

15th May 2015

From: Research

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Lucid Group Communications Limited

WE’RE ON A MISSION To enhance patients’ lives through communication that changes behaviour and improves patient health outcomes....

Latest intelligence

marketing satnav
Mapping at launch: it’s time to update the satnav
How mapping familiar basics can provide a new GPS for market access strategy that drives brand success...
What does the future hold for Medical Affairs?
Lori Lush, Head of Fishawack Medical, reveals why she’s driven to tell impactful scientific stories, the benefits of cross-functional collaboration, and the trends she predicts for the next five years....
EU health fund
An EU emergency health fund to limit the impact of future crises
Leading finance experts propose an Emergency Health Financing Facility to limit the impact of future crises on the EU...

Infographics